$1.04
6.19% yesterday
Nasdaq, Dec 24, 10:44 pm CET
ISIN
US15673T1007
Symbol
IPSC

Century Therapeutics Inc Stock price

$1.04
+0.52 100.00% 1M
+0.45 74.94% 6M
+0.03 2.97% YTD
+0.02 1.46% 1Y
-4.63 81.66% 3Y
-21.79 95.44% 5Y
-21.79 95.44% 10Y
-21.79 95.44% 20Y
Nasdaq, Closing price Wed, Dec 24 2025
+0.06 6.19%
ISIN
US15673T1007
Symbol
IPSC
Industry

Key metrics

Basic
Market capitalization
$90.9m
Enterprise Value
$-41.9m
Net debt
positive
Cash
$132.8m
Shares outstanding
86.5m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
0.8 | 0.8
EV/Sales
negative | negative
EV/FCF
0.4
P/B
0.5
Financial Health
Equity Ratio
45.7%
Return on Equity
-78.4%
ROCE
-10.2%
ROIC
-24.5%
Debt/Equity
0.0
Financials (TTM | estimate)
Revenue
$113.3m | $111.4m
EBITDA
$-9.9m | $-143.9m
EBIT
$-22.8m | $-20.2m
Net Income
$-26.5m | $-11.9m
Free Cash Flow
$-113.2m
Growth (TTM | estimate)
Revenue
4,113.4% | 1,589.8%
EBITDA
91.6% | -19.4%
EBIT
82.6% | 84.9%
Net Income
79.6% | 90.6%
Free Cash Flow
-0.9%
Margin (TTM | estimate)
Gross
-
EBITDA
-8.8% | -129.3%
EBIT
-20.1%
Net
-23.4% | -10.7%
Free Cash Flow
-99.9%
More
EPS
$-0.3
FCF per Share
$-1.3
Short interest
1.0%
Employees
145
Rev per Employee
$50.0k
Show more

Is Century Therapeutics Inc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,079 stocks worldwide.

Century Therapeutics Inc Stock Analysis

Unlock Scores for Free

Analyst Opinions

11 Analysts have issued a Century Therapeutics Inc forecast:

9x Buy
82%
2x Hold
18%

Analyst Opinions

11 Analysts have issued a Century Therapeutics Inc forecast:

Buy
82%
Hold
18%

Financial data from Century Therapeutics Inc

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '25
+/-
%
113 113
4,113% 4,113%
100%
- Direct Costs - -
-
-
- -
-
-
- Selling and Administrative Expenses 31 31
9% 9%
27%
- Research and Development Expense 105 105
5% 5%
93%
-9.94 -9.94
92% 92%
-9%
- Depreciation and Amortization 13 13
5% 5%
11%
EBIT (Operating Income) EBIT -23 -23
83% 83%
-20%
Net Profit -26 -26
80% 80%
-23%

In millions USD.

Don't miss a Thing! We will send you all news about Century Therapeutics Inc directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Century Therapeutics Inc Stock News

Neutral
GlobeNewsWire
30 days ago
PHILADELPHIA, Nov. 25, 2025 (GLOBE NEWSWIRE) -- Century Therapeutics, Inc. (‘Century', NASDAQ: IPSC), a biotechnology company developing induced pluripotent stem cell (iPSC)-derived cell therapies for autoimmune diseases and cancer, today announced that the company will participate in the Piper Sandler 37th Annual Healthcare Conference in New York, NY, as follows:
Neutral
GlobeNewsWire
about one month ago
PHILADELPHIA, Nov. 13, 2025 (GLOBE NEWSWIRE) -- Century Therapeutics, Inc. (‘Century', NASDAQ: IPSC), a biotechnology company developing induced pluripotent stem cell (iPSC)-derived cell therapies for autoimmune diseases and cancer, today reported financial results for the third quarter ended September 30, 2025, and provided a business update.
Neutral
GlobeNewsWire
about one month ago
PHILADELPHIA, Nov. 13, 2025 (GLOBE NEWSWIRE) -- Century Therapeutics, Inc. (‘Century', NASDAQ: IPSC), a biotechnology company developing induced pluripotent stem cell (iPSC)-derived cell therapies for autoimmune diseases and cancer, today announced its first program for Type 1 diabetes (T1D), CNTY-813. The program comprises iPSC-derived beta islets engineered with the company's proprietary Allo...
More Century Therapeutics Inc News

Company Profile

Century Therapeutics, Inc. engages in the development of off-the-shelf cell therapies to advance the course of cancer care. It engages in harnessing the power of adult stem cells to develop curative allogeneic cell therapies for cancer. The company was founded by Marcela Maus and Hiromitsu Nakauchi in 2018 and is headquartered in Philadelphia, PA.

Head office United States
CEO Brent Pfeiffenberger
Employees 145
Founded 2018
Website www.centurytx.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today